---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-106600"
form_type: "8-K"
ticker: "ELAN"
cik: "0001739104"
company_name: "Elanco Animal Health Inc"
filed_at: "2023-10-04T23:59:59+00:00"
generated_at: "2026-06-10T04:53:59.467653+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Elanco to seek shareholder approval for board declassification and enhanced shareholder rights

## Summary
- Board to seek shareholder approval at 2024 annual meeting to declassify Board of Directors.
- Proposal also includes allowing shareholders to amend Bylaws and call special meetings under certain conditions.
- Follows elimination of supermajority vote requirements last year; reflects shareholder engagement since IPO.

## SEC filing metadata
- accession: 0001104659-23-106600
- form_type: 8-K
- ticker: ELAN
- cik: 0001739104
- company_name: Elanco Animal Health Inc
- filed_at: 2023-10-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1739104/000110465923106600/0001104659-23-106600-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1739104/000110465923106600/tm2327596d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-106600
- JSON: https://secwatch.observer/filing/0001104659-23-106600.json
- Plain text: https://secwatch.observer/filing/0001104659-23-106600.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
